Mereo BioPharma reported total assets of $34.71M and total liabilities of $6.06M for the quarter ended Jun 2026, down 44.6% year over year. This balance sheet covers 24 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2017 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.74M | 0.80M | 0.84M | 0.88M | 0.96M | 0.95M | 1.02M | 1.11M | 1.05M | 1.08M | 0.98M | 1.02M | ||||||||||||
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 70.55M | 30.99M | 153.88M | 127.11M | 96.23M | 66.08M | 52.70M | 57.42M | 48.70M | 87.43M | 80.52M | 69.80M | 62.50M | 56.12M | 48.70M | 40.99M | 30.10M | 30.12M | ||||||
| Receivables - NetNet Receivables | 0.89M | 9.88M | ||||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.85M | 1.39M | 0.47M | 1.95M | ||||||||||||||||||||
| Receivables | 1.36M | 9.88M | ||||||||||||||||||||||
| Prepaid Assets | 5.45M | 5.16M | 3.19M | 4.49M | 3.83M | 2.17M | 2.52M | 2.54M | 2.69M | 2.53M | 2.25M | 1.60M | ||||||||||||
| Current Assets | 82.80M | 39.25M | 168.20M | 133.89M | 103.02M | 72.88M | 67.86M | 63.76M | 53.50M | 93.94M | 86.72M | 74.76M | 66.90M | 61.42M | 52.41M | 45.02M | 40.03M | 33.40M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 53.52M | 2.08M | 34.36M | 36.52M | 33.03M | 30.43M | 33.05M | 0.41M | 0.36M | 0.34M | 0.32M | 0.26M | 0.25M | 0.22M | 0.17M | 0.14M | 0.09M | 0.05M | ||||||
| Intangibles | 39.58M | 41.79M | 31.02M | 33.11M | 30.37M | 28.29M | 31.09M | 1.09M | 0.97M | 0.87M | 0.80M | 0.64M | 0.55M | 0.47M | 0.64M | 0.52M | 0.38M | 0.26M | ||||||
| Goodwill & Intangibles | 39.58M | 41.79M | 31.02M | 33.11M | 30.37M | 28.29M | 31.09M | 1.09M | 0.97M | 0.87M | 0.80M | 0.64M | 0.55M | 0.47M | 0.64M | 0.52M | 0.38M | 0.26M | ||||||
| Other Non-Current Assets | 0.61M | 0.47M | 0.44M | 0.38M | 0.38M | 0.40M | 0.39M | 0.40M | 0.39M | 0.39M | ||||||||||||||
| Non-Current Assets | 53.52M | -39.25M | -168.20M | -133.89M | -103.02M | -72.88M | -67.86M | 2.74M | 2.44M | 2.19M | 2.02M | 1.63M | 1.42M | 1.21M | 1.20M | 0.90M | 0.58M | 1.31M | ||||||
| Assets | 136.32M | 66.50M | 55.94M | 96.13M | 88.75M | 76.39M | 68.32M | 62.63M | 53.60M | 45.92M | 40.61M | 34.71M | ||||||||||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 6.82M | 4.40M | 3.06M | 3.37M | 3.55M | 3.61M | 2.39M | 2.35M | 2.46M | 2.70M | 1.75M | 2.44M | 2.92M | 1.14M | 0.88M | 1.33M | 3.23M | 1.12M | ||||||
| Notes Payables | 16.46M | 13.00M | 5.24M | 4.63M | 4.93M | 5.55M | 5.54M | |||||||||||||||||
| Payables | 23.27M | 4.40M | 3.06M | 3.37M | 3.55M | 16.61M | 7.63M | 2.35M | 7.08M | 7.63M | 7.30M | 7.97M | 2.92M | 1.14M | 0.88M | 1.33M | 3.23M | 1.12M | ||||||
| Accumulated Expenses | 5.44M | 5.47M | 2.54M | 3.72M | 3.53M | 4.07M | 2.93M | 5.04M | 4.12M | 2.03M | 2.05M | 2.46M | ||||||||||||
| Other Accumulated Expenses | 1.07M | 1.02M | 0.72M | 3.44M | 2.64M | 1.09M | 0.89M | 0.78M | 0.62M | 0.74M | 0.91M | 1.07M | ||||||||||||
| Short term Debt | 16.46M | 20.09M | 13.00M | 5.24M | ||||||||||||||||||||
| Current Leases | 0.56M | 0.65M | 0.66M | 0.68M | 0.74M | 0.71M | 0.75M | 0.60M | 0.40M | 0.20M | 1.03M | |||||||||||||
| Current Taxes | 2.05M | |||||||||||||||||||||||
| Total Current Liabilities | 27.69M | 11.31M | 13.80M | 16.91M | 44.34M | 28.94M | 21.85M | 9.49M | 11.00M | 15.47M | 14.21M | 13.85M | 7.50M | 7.56M | 6.02M | 4.30M | 6.18M | 5.68M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Non-Current Debt | 18.01M | 21.31M | 25.07M | 19.39M | 4.59M | |||||||||||||||||||
| Convertible Debt | 4.39M | |||||||||||||||||||||||
| Operating Leases | 13.87M | 1.53M | 2.73M | 2.36M | 1.83M | 1.43M | 1.22M | 0.91M | 1.39M | 0.55M | 0.39M | 0.19M | ||||||||||||
| Other Non-Current Liabilities | 44.40M | 67.05M | 47.54M | 11.24M | 8.97M | 0.62M | 0.28M | 0.76M | 0.85M | 0.93M | 1.04M | 0.82M | 0.42M | 0.55M | 0.65M | 0.66M | 0.36M | 0.37M | ||||||
| Total Non-Current Liabilities | 78.44M | 91.58M | 75.99M | 34.88M | 4.09M | 1.80M | 6.80M | 15.20M | 12.24M | 16.55M | 15.17M | 14.60M | 7.82M | 7.91M | 6.35M | 4.34M | 6.20M | 5.69M | ||||||
| Total Liabilities | 106.21M | 102.89M | 89.78M | 51.78M | 48.42M | 30.74M | -44.40M | 28.65M | -54.71M | 15.96M | 13.10M | 17.48M | 16.21M | 15.42M | 8.24M | 8.45M | 7.00M | 5.00M | 6.56M | 6.06M | ||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Total Debt | 50.93M | 21.31M | 25.07M | 19.39M | 20.09M | 26.00M | 15.06M | 4.63M | 4.93M | 5.55M | 5.54M | |||||||||||||
| Common Equity | -19.77M | 112.77M | 118.63M | 87.63M | 72.57M | 44.40M | 49.66M | 54.71M | 50.54M | 42.84M | 78.65M | -72.54M | 60.97M | 60.08M | 54.18M | 46.60M | 40.92M | 34.05M | 28.65M | |||||
| Liabilities and Shareholders Equity | 136.32M | 66.50M | 55.94M | 96.13M | 88.75M | 76.39M | 68.32M | 62.63M | 53.60M | 45.92M | 40.61M | 34.71M | ||||||||||||
| Treasury Shares | 0.92M | |||||||||||||||||||||||
| Retained Earnings | -336.10M | -408.93M | -415.97M | -400.32M | -398.10M | -388.43M | -428.21M | 486.11M | 486.93M | 534.73M | 536.43M | 539.64M | 544.27M | 546.33M | 548.04M | 549.62M | 551.02M | 552.34M |